CAMBRIDGE, Mass.--(BUSINESS WIRE)--April 26, 2006--Dyax Corp. (Nasdaq: DYAX - News) today announced financial results for the first quarter ended March 31, 2006. The Company will host a webcast and conference call at 10 a.m. (ET) this morning to report financial results and corporate progress for the quarter, and to provide an update on the Company’s lead DX-88 program in hereditary angioedema (HAE).
